| P&O Manager,People Partner |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Human Resources |
Септ. 03, 2024 |
| (高级)地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Юни 21, 2024 |
| Associate Marketing |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Юли 08, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Юли 17, 2024 |
| Medical Advisor |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Септ. 11, 2024 |
| (Senior) MSL Manager, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Септ. 18, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Септ. 18, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 15, 2024 |
| (Sr.) Medical Advisor, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Окт. 18, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 18, 2024 |
| SSO Finance Specialist |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Окт. 20, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 25, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 25, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Окт. 25, 2024 |
| ASCVD Brand Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| Sr. Medical Science Liaison, ASCVD |
Seoul |
South Korea |
International |
Innovative Medicines |
Research & Development |
Септ. 05, 2024 |
| P&R Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Market Access |
Септ. 27, 2024 |
| RLT Customer Service Coordinator |
Seoul |
South Korea |
International |
Innovative Medicines |
Sales |
Авг. 27, 2024 |
| Renal Medical Lead |
Seoul |
South Korea |
International |
Innovative Medicines |
Research & Development |
Септ. 01, 2024 |
| Patient Support Program Lead |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Септ. 24, 2024 |
| Senior Patient Safety Specialist |
Seoul |
South Korea |
Development |
Innovative Medicines |
Research & Development |
Окт. 20, 2024 |
| Engagement Services Senior Expert (Japanese Speaker) |
Selangor |
Malaysia |
People & Organization |
CTS |
Human Resources |
Септ. 04, 2024 |
| Hire to Retire Services Expert |
Selangor |
Malaysia |
People & Organization |
CTS |
Human Resources |
Септ. 05, 2024 |
| Manufacturing Systems Expert |
Selangor |
Malaysia |
Operations |
Innovative Medicines |
Technical Operations |
Септ. 05, 2024 |
| Treasury & Cash Management Team Lead |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Авг. 12, 2024 |
| R2R Senior Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 02, 2024 |
| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Site Operations Lead |
Selangor |
Malaysia |
Operations |
CTS |
BD&L & Strategic Planning |
Окт. 08, 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Окт. 14, 2024 |
| R2R Team Lead - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 10, 2024 |
| Hire to Retire Services Specialist |
Selangor |
Malaysia |
People & Organization |
CTS |
Human Resources |
Авг. 19, 2024 |
| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Авг. 19, 2024 |
| FRA Technical Accounting & Special Projects APMA |
Selangor |
Malaysia |
Operations |
CTS |
Audit & Finance |
Авг. 22, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Авг. 22, 2024 |
| Sr Specialist DDIT IM JP & APMA Soln Int |
Selangor |
Malaysia |
Operations |
CTS |
Technology Transformation |
Авг. 22, 2024 |
| Hire to Retire Services Specialist |
Selangor |
Malaysia |
People & Organization |
CTS |
Human Resources |
Май 19, 2024 |
| P2P & T&E Specialist (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Юни 05, 2024 |
| P2P & T&E Business Partner (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Юни 12, 2024 |
| R2R Senior Specialist GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Юни 13, 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Авг. 29, 2024 |
| Regional Sourcing Manager APAC-Indirect (Japanese Speaker) |
Selangor |
Malaysia |
Operations |
CTS |
Procurement |
Юли 22, 2024 |
| Project Manager |
Selangor |
Malaysia |
Operations |
CTS |
Technology Transformation |
Септ. 03, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Юли 28, 2024 |
| P2P & T&E Specialist (Arabic Speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Юли 05, 2024 |
| ERP Assurance Senior Consultant |
Selangor |
Malaysia |
Operations |
CTS |
Audit & Finance |
Юли 17, 2024 |
| S2P Business Partner (Korean speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Септ. 24, 2024 |
| Specialist QA Operations |
Selangor |
Malaysia |
Operations |
Innovative Medicines |
Quality |
Окт. 24, 2024 |
| Product Specialist |
Selangor |
Malaysia |
International |
Innovative Medicines |
Sales |
Окт. 15, 2024 |
| Senior Product Specialist |
Selangor |
Malaysia |
International |
Innovative Medicines |
Sales |
Окт. 15, 2024 |